SEVERINA
DOMÍNGUEZ FERNÁNDEZ
Argitalpenak (23) SEVERINA DOMÍNGUEZ FERNÁNDEZ argitalpenak
2022
-
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study
Frontiers in Pharmacology, Vol. 13
-
Urgent and unexpected findings in oncology and hematology patients: a practical approach to imaging
Radiologia, Vol. 64, Núm. 5, pp. 464-472
2021
-
Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
Annals of Medicine, Vol. 53, Núm. 1, pp. 762-769
2019
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 189-199
2017
-
Valoración del coste económico del cáncer colorrectal según estadio tumoral
Cirugia Espanola, Vol. 95, Núm. 2, pp. 89-96
2016
-
Growing teratoma syndrome: An unusual evolution of treated ovarian immature teratoma - A case report
European Journal of Gynaecological Oncology, Vol. 37, Núm. 5, pp. 729-731
2010
-
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 149-157
2004
-
Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy
Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, Vol. 6, Núm. 1, pp. 22-29
-
Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy
Clinical and Translational Oncology, Vol. 6, Núm. 1, pp. 22-29
2003
-
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
Annals of Oncology, Vol. 14, Núm. 6, pp. 867-872
-
Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer
Lung Cancer, Vol. 39, Núm. 1, pp. 77-84
2002
-
Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 6, pp. 588-590
1998
-
Informacion en oncologia: Evaluacion de un modelo basado en la autonomia del paciente
Oncologia, Vol. 21, Núm. 12, pp. 33-38
1995
-
Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: A preliminary report
International Journal of Radiation Oncology, Biology, Physics, Vol. 33, Núm. 3, pp. 675-682
1994
-
Aztreonam in association with piperacillin as an empirical antibiotic treatment in febrile granulocytopenic patients with solid tumors
Oncology Reports, Vol. 1, Núm. 1, pp. 233-236
1993
-
Ifosfamide in advanced epidermoid head and neck cancer
Cancer Chemotherapy and Pharmacology, Vol. 31, Núm. 4, pp. 340-342